Creative Medical Technology Holdings, Inc. Net Fee Amt
Creative Medical Technology Holdings, Inc. (CELZ) had Net Fee Amt of $0 as of 2026-07-22, per its S-3 filed 2026-07-24.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-24
- 2026-07-22: Net Fee Amt $0.00.
- 2026-06-23: Net Fee Amt $2.48K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-22 | $0.00 S-3 · filed 2026-07-24 |
| 2026-06-23 | $2.48K S-1 · filed 2026-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |